C4 Therapeutics, Inc.
US ˙ NasdaqGS ˙ US12529R1077

SecurityCCCC / C4 Therapeutics, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in CCCC / C4 Therapeutics, Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of C4 Therapeutics, Inc. (US:CCCC) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 30,658 shares of C4 Therapeutics, Inc.. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (CCCC) in the form of stock options. The firm currently holds call options representing 29,500 of underlying shares valued at $77,585 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CCCC / C4 Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F C4 THERAPEUTICS COM 12529R107 0 -100.00 0
2026-02-11 2025-12-31 13F C4 THERAPEUTICS COM 12529R107 30,658 22,822 291.25 59 0.0000
2025-11-12 2025-09-30 13F C4 THERAPEUTICS COM 12529R107 7,836 7,836 0 0.0000
2025-05-12 2025-03-31 13F C4 THERAPEUTICS COM 12529R107 0 -6,871 -100.00 0 0.0000
2025-02-11 2024-12-31 13F C4 THERAPEUTICS COM 12529R107 6,871 -73,628 -91.46 0 0.0000
2024-11-08 2024-09-30 13F C4 THERAPEUTICS COM 12529R107 80,499 38,398 91.20 0 0.0003
2024-07-25 2024-06-30 13F C4 THERAPEUTICS COM 12529R107 42,101 -7,168 -14.55 0 0.0001
2024-04-25 2024-03-31 13F C4 THERAPEUTICS COM 12529R107 49,269 -45,751 -48.15 0 0.0002
2024-02-02 2023-12-31 13F C4 THERAPEUTICS COM 12529R107 95,020 95,020 1 0.0003
2023-04-27 2023-03-31 13F C4 THERAPEUTICS COM 12529R107 0 -44 -100.00 0 0.0000
2023-02-02 2022-12-31 13F C4 THERAPEUTICS COM 12529R107 44 -2,145 -97.99 0 -100.00
2022-11-04 2022-09-30 13F C4 THERAPEUTICS COM 12529R107 2,189 -172 -7.29 19 11.76 0.0000
2022-08-03 2022-06-30 13F C4 THERAPEUTICS COM 12529R107 2,361 -34,885 -93.66 17 -98.12 0.0000
2022-05-02 2022-03-31 13F C4 THERAPEUTICS COM 12529R107 37,246 37,246 903 0.0008
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F C4 THERAPEUTICS CALL Call 29,500 400.00 78 600.00 n/a n/a n/a
2026-02-11 2025-12-31 13F C4 THERAPEUTICS CALL Call 5,900 -80.00 11 n/a n/a n/a
2025-11-12 2025-09-30 13F C4 THERAPEUTICS CALL Call 29,500 25.53 0 n/a n/a n/a
2025-08-05 2025-06-30 13F C4 THERAPEUTICS CALL Call 23,500 0.86 0 n/a n/a n/a
2025-05-12 2025-03-31 13F C4 THERAPEUTICS CALL Call 23,300 3,783.33 0 n/a n/a n/a
2025-02-11 2024-12-31 13F C4 THERAPEUTICS CALL Call 600 -99.23 0 n/a n/a n/a
2024-11-08 2024-09-30 13F C4 THERAPEUTICS CALL Call 77,800 -6.60 0 n/a n/a n/a
2024-07-25 2024-06-30 13F C4 THERAPEUTICS CALL Call 83,300 162.78 0 n/a n/a n/a
2024-04-25 2024-03-31 13F C4 THERAPEUTICS CALL Call 31,700 -65.91 0 n/a n/a n/a
2024-02-02 2023-12-31 13F C4 THERAPEUTICS CALL Call 93,000 4,794.74 1 n/a n/a n/a
2023-11-01 2023-09-30 13F C4 THERAPEUTICS CALL Call 1,900 -90.26 0 n/a n/a n/a
2023-08-04 2023-06-30 13F C4 THERAPEUTICS CALL Call 19,500 -15.58 0 n/a n/a n/a
2023-04-27 2023-03-31 13F C4 THERAPEUTICS CALL Call 23,100 5,675.00 0 n/a n/a n/a
2023-02-02 2022-12-31 13F C4 THERAPEUTICS CALL Call 400 -60.00 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F C4 THERAPEUTICS CALL Call 1,000 233.33 8 300.00 n/a n/a n/a
2022-08-03 2022-06-30 13F C4 THERAPEUTICS CALL Call 300 -97.78 2 -99.39 n/a n/a n/a
2022-05-02 2022-03-31 13F C4 THERAPEUTICS CALL Call 13,500 132.76 327 75.81 n/a n/a n/a
2022-02-23 2021-12-31 13F/A C4 THERAPEUTICS CALL Call 5,800 186 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F C4 THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2026-02-11 2025-12-31 13F C4 THERAPEUTICS PUT Put 300 -99.37 1 n/a n/a n/a
2025-11-12 2025-09-30 13F C4 THERAPEUTICS PUT Put 47,800 0 n/a n/a n/a
2025-08-05 2025-06-30 13F C4 THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2025-05-12 2025-03-31 13F C4 THERAPEUTICS PUT Put 2,500 -13.79 0 n/a n/a n/a
2025-02-11 2024-12-31 13F C4 THERAPEUTICS PUT Put 2,900 -94.75 0 n/a n/a n/a
2024-11-08 2024-09-30 13F C4 THERAPEUTICS PUT Put 55,200 -36.26 0 n/a n/a n/a
2024-07-25 2024-06-30 13F C4 THERAPEUTICS PUT Put 86,600 14.55 0 n/a n/a n/a
2024-04-25 2024-03-31 13F C4 THERAPEUTICS PUT Put 75,600 -65.19 1 -100.00 n/a n/a n/a
2024-02-02 2023-12-31 13F C4 THERAPEUTICS PUT Put 217,200 24,033.33 1 n/a n/a n/a
2023-11-01 2023-09-30 13F C4 THERAPEUTICS PUT Put 900 0 n/a n/a n/a
2023-08-04 2023-06-30 13F C4 THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2023-04-27 2023-03-31 13F C4 THERAPEUTICS PUT Put 200 100.00 0 n/a n/a n/a
2023-02-02 2022-12-31 13F C4 THERAPEUTICS PUT Put 100 -97.62 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F C4 THERAPEUTICS PUT Put 4,200 -2.33 36 12.50 n/a n/a n/a
2022-08-03 2022-06-30 13F C4 THERAPEUTICS PUT Put 4,300 975.00 32 255.56 n/a n/a n/a
2022-05-02 2022-03-31 13F C4 THERAPEUTICS PUT Put 400 9 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.